Open AccessUsing the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
Author(s) -
Yi Yang,
Yanzhao Zhou,
Mengjie Zhang,
Yujing Xin,
Yi Chen,
Qi-Wen Fan,
Xiao Li,
Xi Wei,
Qiang Li,
Xiang Zhou,
Jinxue Zhou
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s308587
Subject(s) - nomogram , medicine , receiver operating characteristic , cohort , hepatocellular carcinoma , radiofrequency ablation , framingham risk score , population , cancer , liver cancer , surgery , oncology , ablation , disease , environmental health
This study was conducted to explore the application of age-male-ALBI-platelets (aMAP) score for predicting late recurrence of hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA) and develop an aMAP score based-nomogram to predict prognosis in Chinese population.